Bayer U.S. Focus Will Be Oncology, Blood Products And OTCs

Bayer will focus its U.S. pharmaceutical operations on OTCs, oncology and blood products following an agreement giving Schering-Plough marketing rights to its primary care brands

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet